A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis

Author(s):
Strijbos, E.; Huijbers, M.G.; Es, I.E. van; Alleman, I.; Ostaijen-ten Dam, M.M. van; Bakker, J.; Zwet, E.W. van (0000-0001-5537-3179); Jol-van der Zijde, C.M.; Tol, M.D. van; Verschuuren, J.J.
Published
2017
Publication type
Article / Letter to editor
TetanusVaccinationAutoimmune diseaseMyasthenia gravisImmunosuppressionAntibodies
Date issued
2017-11-01
Language
English
Is part of
Vaccine (2017), Vol. 35, no. 46, p. 6290-6296
hdl
1887/115036
doi
10.1016/j.vaccine.2017.09.078